124 related articles for article (PubMed ID: 1361703)
1. [The importance of S-100 protein positive Langerhans cells and Leu-M1 positive tumor cells for prognosis of papillary thyroid cancer].
Willgeroth C; Floegel R; Rösler B
Zentralbl Chir; 1992; 117(11):603-6. PubMed ID: 1361703
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].
Schröder S; Dralle H; Bay V; Böcker W
Acta Med Austriaca; 1989; 16(1):2-5. PubMed ID: 2711816
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.
Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
Virchows Arch A Pathol Anat Histopathol; 1987; 411(5):435-9. PubMed ID: 3116758
[TBL] [Abstract][Full Text] [Related]
4. Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.
Schröder S; Bay V; Dumke K; Kremens B; Müller-Gärtner HW; Böcker W; Kastendieck H
Virchows Arch A Pathol Anat Histopathol; 1990; 416(4):367-71. PubMed ID: 2106754
[TBL] [Abstract][Full Text] [Related]
5. Leu-M 1 immunoreactivity in papillary carcinomas of the thyroid gland; microcarcinoma, encapsulated, conventional and diffuse sclerosing subtypes.
Alejo M; Peiro G; Oliva E; Matias-Guiu X
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):447-8. PubMed ID: 1750190
[No Abstract] [Full Text] [Related]
6. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
Kornfehl J; Wilfing A; Hermann M
Laryngorhinootologie; 1994 Apr; 73(4):183-8. PubMed ID: 8011021
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of e-cadherin in papillary thyroid carcinoma].
Walgenbach S; Sternheim E; Bittinger F; Görges R; Andreas J; Junginger T
Chirurg; 1998 Feb; 69(2):186-90. PubMed ID: 9551263
[TBL] [Abstract][Full Text] [Related]
8. Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2013 Apr; 121(4):206-13. PubMed ID: 23042745
[TBL] [Abstract][Full Text] [Related]
9. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.
Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
Am J Clin Pathol; 1988 Mar; 89(3):295-300. PubMed ID: 3348166
[TBL] [Abstract][Full Text] [Related]
10. [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].
Larena A; Vierbuchen M; Schröder S; Larena-Avellaneda A; Hadshiew I; Fischer R
Langenbecks Arch Chir; 1996; 381(2):102-13. PubMed ID: 8649124
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.
Ghali VS; Jimenez EJ; Garcia RL
Hum Pathol; 1992 Jan; 23(1):21-5. PubMed ID: 1371984
[TBL] [Abstract][Full Text] [Related]
12. Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.
Neuhold N; Längle F; Gnant M; Hollenstein U; Niederle B
J Cancer Res Clin Oncol; 1992; 118(8):629-34. PubMed ID: 1355485
[TBL] [Abstract][Full Text] [Related]
13. [Histological and immuno-morphological characteristics of differentiated cancer of the thyroid gland].
Shevchenko SI; Iakimova TP; Shevchenko RS
Sov Med; 1991; (4):19-21. PubMed ID: 1871617
[TBL] [Abstract][Full Text] [Related]
14. Oncocytic papillary carcinoma with lymphoid stroma (Warthin-like tumour) of the thyroid: a distinct entity with favourable prognosis.
Ludvíková M; Ryska A; Korabecná M; Rydlová M; Michal M
Histopathology; 2001 Jul; 39(1):17-24. PubMed ID: 11454040
[TBL] [Abstract][Full Text] [Related]
15. Detection of Leu-19 (CD56) antigen on human thyroid epithelial cells by an immunohistochemical method.
Migita K; Eguchi K; Kawakami A; Ida H; Fukuda T; Kurata A; Ishikawa N; Ito K; Nagataki S
Immunology; 1991 Feb; 72(2):246-9. PubMed ID: 1707851
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
[TBL] [Abstract][Full Text] [Related]
17. Thyromegaly secondary to simultaneous papillary carcinoma and histiocytosis X. Report of a case and review of the literature.
Goldstein N; Layfield LJ
Acta Cytol; 1991; 35(4):422-6. PubMed ID: 1927175
[TBL] [Abstract][Full Text] [Related]
18. [The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer].
Böttger T; Potratz D; Schernus B; Klupp J; Stöckle M; Junginger T
Chirurg; 1994 Mar; 65(3):190-3. PubMed ID: 8194403
[TBL] [Abstract][Full Text] [Related]
19. [Differentiated cancers].
Görtz G; Häring R
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():961-6. PubMed ID: 1983687
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of leu 7 and PCNA expression in thyroid neoplasms.
Fucich LF; Freeman SM; Marrogi AJ
Biotech Histochem; 1996 Nov; 71(6):298-303. PubMed ID: 8957557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
